ArticleCureus2026

Uptake of Technetium-99m Sestamibi (99mTc-MIBI) as a Predictor of Fracture Risk in the Appendicular Skeleton of Multiple Myeloma Patients at a National Reference Center.

Reyna Sarahi Bañuelos Balderas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.